Table 2 Baseline characteristics in hemodialysis patients (N = 144).
Variables | CHD/CS (n = 27) | Non CHD/CS (n = 117) | P |
|---|---|---|---|
Age, years | 65.8 ± 13.6 | 62.3 ± 12.3 | 0.226 |
HD vintage, years | 11.2 ± 8.1 | 10.7 ± 7.6 | 0.784 |
Sex | 0.122 | ||
Female | 9 (33.3%) | 61 (52.1%) | |
Male | 18 (66.7%) | 56 (47.9%) | |
DM | 8 (29.6%) | 18 (15.4%) | 0.145 |
Etiology | 0.862 | ||
Primary kidney disease | 8 (29.6%) | 42 (35.9%) | |
Systemic disease | 15 (55.6%) | 56 (47.9%) | |
Others | 4 (14.8%) | 19 (16.2%) | |
Laboratory measurements | |||
Hemoglobin, g/dL | 11 ± 1.0 | 10.6 ± 1.3 | 0.139 |
Total leukocytes, 109/L | 6.7 ± 2.5 | 6.1 ± 2.4 | 0.290 |
Albumin, g/dL | 3.9 ± 0.4 | 3.9 ± 0.3 | 0.930 |
BUN, mg/dL | 73 (37–111) | 68 (32–151) | 0.339 |
Cr, mg/dL | 10.6 ± 2.5 | 10.3 ± 2.3 | 0.661 |
Total cholesterol, mg/dL | 143 (102–195) | 151 (94–314) | 0.069 |
Triglyceride, mg/dL | 110 (53–290) | 102 (30–300) | 0.664 |
HDL-C, mg/dL | 42.6 ± 13.4 | 45.8 ± 15.4 | 0.285 |
HDL-2b, % | 20.0 ± 7.7 | 24.9 ± 9.1 | 0.006 |
HDL-3, % | 34.9 ± 11.0 | 29.6 ± 9.8 | 0.026 |
LDL-C, mg/dL | 78.6 ± 26.7 | 88.1 ± 34.1 | 0.122 |
Intact-PTH, pg/ml | 199.7 (17.2–2819.9) | 303.1 (2.4–2130) | 0.865 |
hs-CRP, mg/L | 8.7 ± 12.4 | 6.8 ± 13.9 | 0.469 |
